
EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: A secondary analysis of RTOG 0324
Keywords: ستوکسیمب، اِربیتاکس، ستوکسیمب; Clinical trials identifier NCT00081302; RTOG 0324; Cetuximab; Inoperable lung cancer; Erbitux;